Albuquerque Suboxone® Clinic

 

Medication-assisted treatment has been considered the gold standard of care for more than 50 years. The FDA approved buprenorphine as an MAT choice in 2002. Patients will work with their medical provider to determine the best treatment option for them. Recovery Services of New Mexico Isleta offers both buprenorphine and buprenorphine compounds to our patients struggling with opioid addiction.

​

• Buprenorphine: Classified as a partial opioid agonist, buprenorphine attaches to the opioid receptors in the brain as any prescription or illicit opioid does, but does not affect the brain to the same degree. It is able to prevent withdrawal symptoms by attaching to the receptors, but its’ “ceiling effect” prevents it from causing the euphoria or “high” experienced with other opioids.

 

• Sublocade™: Sublocade is an extended-release form of buprenorphine administered as a once monthly injection. It is designed to deliver the buprenorphine at a controlled, consistent rate over the period. Sublocade can cause serious harm if injected directly into the vein, so it must be administered in office by a healthcare professional, but it offers the same benefits as daily buprenorphine.

 

• Suboxone®: Buprenorphine compounds, most commonly known by the brand name Suboxone®, utilize buprenorphine combined with the full opioid agonist naloxone. The compound provides the same withdrawal relief, but the naloxone offers additional blocking properties and causes immediate withdrawal symptoms if injected, making it a deterrent to misuse.

 

Buprenorphine with naloxone is offered in different formulations under a number of brand names including:

​

                             Suboxone®      Bunavail®       Zubsolv® 

​

Depending on the medication, it may be administered as a film or tablet dissolved under the tongue.